Viridos
Viridos: Innovating genomic solutions for energy and environmental challenges through synthetic genomics and advanced biofuels.
Founded
2005Viridos: Innovating genomic solutions for energy and environmental challenges through synthetic genomics and advanced biofuels.
Founded with the mission to tackle global energy and environmental challenges, Viridos leverages synthetic genomics to develop innovative genomic-driven solutions. The company specializes in designing and developing microbes for industrial processes and environmental applications, focusing on advanced biofuels derived from algae. Viridos aims to decarbonize heavy transportation sectors that lack viable paths to reduce carbon emissions, offering renewable energy solutions to meet the world's growing energy demands.
Notable figures affiliated with Viridos include leading scientists and industry experts in synthetic biology and bioengineering. The company has attracted significant investment from forward-thinking venture capital firms focused on sustainable technologies. Key achievements include pioneering advancements in microbial cultivation technologies and the successful development of algal biofuel, positioning Viridos as a crucial player in the renewable energy sector. Their work has a profound impact on reducing carbon footprints across various industries, contributing significantly to global climate change mitigation efforts.
Companies similar to Viridos include Wild Microbes, Yali Bio, Vir Biotechnology and Virogenomics.
Viridos was founded in 2005.
Viridos' headquarters is located in Los Angeles, CA, US.
Viridos' most recent funding round was for $25M (USD) in March 2023.
As of Mar 13, 2023, Viridos has raised a total of $202M (USD).
Viridos has 750 employees as of Feb 4, 2024.
Vir Biotechnology
vir.bio
